MCCORMICK FRANK

Track

Insider profile

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -24% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MCCORMICK FRANK's trades of BridgeBio Pharma, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
232.06
Quantity 83,952 -27.8%
Value US$1,096,299
Transaction date
Planned sale
Price
68.05
Quantity 74,012 +34.8%
Value US$3,085,123
Transaction date
Planned sale
Price
193.54
Quantity 71,643 +36.7%
Value US$3,426,806
Transaction date
Planned sale
Price
65.48
Quantity 111,755 -12.7%
Value US$7,317,315
Transaction date
Proposed sale
Price
53.14
Quantity 74,000
Value US$3,932,057
Transaction date
Planned sale
Price
44.23
Quantity 100,000 -10.2%
Value US$4,422,800
Transaction date
Planned sale
Price
42.06
Quantity 100,000 -13.7%
Value US$4,206,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-31 2025-10-29
PlS Planned sale
83,952 -27.8%
232.06
US$1,096,299 		83,952 -27.8% 232.06 US$1,096,299
2025-10-31 2025-10-29
PlS Planned sale
74,012 +34.8%
68.05
US$3,085,123 		74,012 +34.8% 68.05 US$3,085,123
2025-10-31 2025-10-29
PlS Planned sale
71,643 +36.7%
193.54
US$3,426,806 		71,643 +36.7% 193.54 US$3,426,806
2025-10-31 2025-10-29
PlS Planned sale
31,116 -4.1%
66.20
US$2,059,749 		31,116 -4.1% 66.20 US$2,059,749
2025-10-31 2025-10-29
PlS Planned sale
111,755 -12.7%
65.48
US$7,317,315 		111,755 -12.7% 65.48 US$7,317,315
2025-10-29 2025-10-29
PrS Proposed sale
198,359
66.58
US$13,206,532 		198,359 66.58 US$13,206,532
2025-10-29 2025-10-27
PlS Planned sale
1,641 -0.2%
65.00
US$106,665 		1,641 -0.2% 65.00 US$106,665
2025-10-27 2025-10-27
PrS Proposed sale
1,641
65.00
US$106,665 		1,641 65.00 US$106,665
2025-09-08 2025-09-05
S Sale
74,000 -47.1%
53.16
US$3,933,544 		74,000 -47.1% 53.16 US$3,933,544
2025-09-05 2025-09-05
PrS Proposed sale
74,000
53.14
US$3,932,057 		74,000 53.14 US$3,932,057
2025-06-26 2025-06-24
PlS Planned sale
100,000 -10.2%
44.23
US$4,422,800 		100,000 -10.2% 44.23 US$4,422,800
2025-06-24 2025-06-24
PrS Proposed sale
100,000
44.23
US$4,422,803 		100,000 44.23 US$4,422,803
2023-12-28 2023-12-26
PlS Planned sale
100,000 -13.7%
42.06
US$4,206,000 		100,000 -13.7% 42.06 US$4,206,000
2023-12-26 2023-12-26
PrS Proposed sale
100,000
42.06
US$4,206,443 		100,000 42.06 US$4,206,443
2020-11-17 2020-11-13
S Sale
10,069 -0.8%
43.57
US$438,688 		10,069 -0.8% 43.57 US$438,688
2020-11-17 2020-11-13
S Sale
58,299 -4.6%
42.91
US$2,501,546 		58,299 -4.6% 42.91 US$2,501,546
2020-11-17 2020-11-13
S Sale
31,632 -2.4%
42.22
US$1,335,535 		31,632 -2.4% 42.22 US$1,335,535